Oxylaxon (Oxycodone Hydrochloride, Naloxone Hydrochloride Dihydrate)

Oxycodone Hydrochloride, the active ingredient in Oxylaxon, is an opioid analgesic presented as a strength/form for oral use. It treats moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oxylaxon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxylaxon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxylaxon combines an opioid agonist with an antagonist to provide analgesia while reducing misuse potential.

- Moderate to severe acute pain: alleviates pain intensity in postoperative or injury‑related settings. - Chronic cancer‑related pain: maintains long‑term pain control for oncology patients. - Severe chronic non‑cancer pain: offers sustained relief when other opioids are inadequate.

Oxylaxon may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: mild to moderate upset stomach. - Drowsiness: increased sedation. - Dizziness: light‑headed feeling. - Dry mouth: reduced salivation. - Sweating: excessive perspiration.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Opioid use disorder: risk of dependence with prolonged use. - Hepatic impairment: liver function deterioration. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Seizures: rare convulsive episodes.

When prescribing Oxylaxon, clinicians should consider several safety measures.

- Assess pain severity and prior opioid exposure: ensure appropriate indication. - Evaluate respiratory function: monitor for depression, especially after dose changes. - Review hepatic and renal function: adjust use in impairment. - Avoid concurrent CNS depressants: limit additive sedation risk. - Educate patients on proper use and disposal: reduce accidental ingestion. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Oxylaxon can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: combined use markedly increases respiratory depression risk. - CNS depressants: other sedatives amplify sedation and respiratory effects. - MAO inhibitors: may provoke severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase serotonin levels, raising serotonin syndrome risk. - Antihistamines: can enhance drowsiness. - Diuretics: may affect blood pressure control. - CYP3A4 inhibitors (e.g., ketoconazole): raise oxy‑c‑d levels, requiring dose adjustment.